A Phase 2 clinical study revealed that BiovaxID, a personalized anti-cancer vaccine, induced anti-tumor T-cell responses in most patients despite B-cell depletion. The overall survival rate was 89%, showing the vaccine's potential to treat other types of non-Hodgkin's lymphoma.
Ira Mellman, a leading expert in cell biology, has been elected an Associate Member of the European Molecular Biology Organization (EMBO) for his groundbreaking research on immune responses and cell polarity. This recognition is a testament to his dedication to advancing scientific knowledge and collaboration.
A study published in Tissue and Cell reveals that defects in the adult stem cell niche can lead to breast cancer development. Researchers found that each cell population plays a different role in breast cancer and that environmental factors influence the risk of becoming cancerous.
Tomio Joins Blackwell Publishing to Advance Chemical Biology & Drug Design, Focusing on Smart Chemistry and Innovative Drug Development. Tomio brings extensive experience in small-molecule drug discovery and multidisciplinary research at ARIAD Pharmaceuticals.
Researchers at University of Illinois Chicago have found a new connection between the signaling protein Raf Kinase Inhibitor Protein (RKIP) and cell migration. By studying the compound locostatin, they identified RKIP as a key player in controlling cell movement, suggesting it as a potential target for anti-cancer strategies.
Researchers uncover 65 protein tags that can be used to force proteins to the cell surface, potentially revolutionizing drug and vaccine development. The discovery may help overcome obstacles in studying important proteins, such as those detecting odors or faulty in cystic fibrosis.
A recent study published in Nature Structural & Molecular Biology has identified a key protein, Upf1, that regulates histone production during cell division. The research suggests that an imbalance in DNA and histone production is lethal for cells and may be crucial in understanding tumor growth.
The Burnham Institute was selected by NIH to receive a $3M grant for exploratory center in hESC research. The center will support pilot projects, core facilities, and training for scientists.
A new study has identified a protein called DOCK180 that senses chemicals inducing cell migration. This finding may lead to treatments halting cancer metastasis and immune disorders like arthritis and asthma by inhibiting inappropriate cell movement.
Notch protein plays a crucial role in directing early T-cell development in the thymus, a small organ under the breastbone near the heart. This study provides new insights into the process, shedding light on how Notch signaling contributes to T-cell differentiation and potentially improving outcomes for transplant patients.
Dirk Inzé's pioneering work on plant cell division has revealed similarities to human cell regulation, shedding light on the mechanisms driving cancer and informing potential treatments. His research also explores the potential of plants to produce sustainable energy through photosynthesis, offering a promising solution for the world's...
PLOS Biology has achieved a record-breaking impact factor of 13.9, placing it above established journals such as EMBO Journal and Current Biology. This milestone reflects the journal's growing influence in the scientific community, particularly among open-access advocates.
Researchers have successfully cloned mice using direct nuclear transfer from terminally differentiated natural killer T cells. The cloned pups and their placentas exhibit rearranged T cell receptor genomic loci specific to NKT cells, demonstrating that fully differentiated cell nuclei can support embryo and placenta development.
The Tri-Institutional Stem Cell Initiative aims to decipher molecular codes responsible for human cellular diversity and design cell-based therapies. This collaboration will bring together researchers from Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, and The Rockefeller University to explore stem cell biology.
The Rockefeller University and Memorial Sloan Kettering Cancer Center are collaborating on stem cell research to understand the biology of stem cells. Researchers are working together to identify cancer stem cells and develop cell-based therapeutic strategies for diseases like Parkinson's.
Scientists at UCSB have discovered a protein called vacuolar ATPase that naturally prevents inappropriate cell fusion, which can lead to cancer metastasis. This finding may pave the way for new treatments to enhance organ regeneration by stem cells, prevent cancer progression, and control fertility.
A study published in Developmental Cell identifies two genes, HES-1 and HLF, that regulate human blood stem cell behavior. These genes enhance cell-cycle progression and inhibit premature cell death in hematopoietic stem cells.
Scientists have identified 35 genes essential for regeneration in planarians, a discovery that could lead to new insights into human regenerative biology and the development of potential treatments for diseases. The study also highlights the potential of planarians as a genetically sound model for human biology.
Molecular Systems Biology is a new journal that publishes papers on complex biological systems using molecular components and their interactions. The journal features innovative technology for formal descriptions of biological systems and sharing of data in widely-used XML-based formats.
Researchers found a gene, Elp1, that regulates cell polarity in yeast, offering insight into Familial Dysautonomia's pathogenesis. The protein plays an essential role in cell growth and neuron development, which may be disrupted in FD patients.
The study found that PTEN and PI3K are required for cell migration and division, raising hopes for new treatments in cancer and inflammatory disorders. The researchers also discovered a novel mechanism by which cells regulate PIP3 levels to control cell migration.
Listeria uses host cell lipids to move within cells and spread through the body. The bacteria hijack the host cell's actin cytoskeleton using two membrane lipids, PIP2 and PIP3, which are essential for their movement.
Researchers at UCLA's new $20 million Institute for Stem Cell Biology and Medicine are exploring various approaches to combat HIV, cancer and neurological disorders. The institution aims to harness the power of embryonic and adult stem cells to develop revolutionary new treatments.
Dr. Somerman received the award for her outstanding contributions to oral biology research, recognized as the Association's highest honor. The IADR Research in Oral Biology Distinguished Scientist Award is one of 15 bestowed annually by the IADR.
Dr Hylander's pioneering research on mandible mechanics and jaw joint loading has significantly advanced the field of craniofacial biology. His work has been widely applied and recognized with awards including the NIH Merit Award.
A new study found that cholesterol plays a crucial role in regulating cell signals by interacting with the oxysterol binding protein (OSBP), which controls the deactivation of ERK. This mechanism helps maintain proper levels of active ERK, preventing cancer growth.
Researchers find that adult stem cells are maintained by local environment signals that block gene expression, preventing differentiation. The microenvironment captures cells and prevents them from becoming other types of cells.
Alan Hall's work on Rho and Rac GTPases is crucial for understanding how epithelial tumour cells become metastatic. Svante Pääbo receives the Louis-Jeantet Prize for medicine to study genes involved in human evolution, including FOXP2 related to speech development.
A team of researchers from Duke University has successfully used micromanipulation to study the separation of sister chromatids in cell division. Their experiments revealed that chromatids are initially attached but then separate at their centers, with linkages playing a crucial role in their separation.
Scientists have successfully cloned primates up to the blastocyst stage, a developmental milestone for embryonic stem cell research and potential treatments for diseases such as diabetes and Parkinson's. The breakthrough could pave the way for deriving human embryonic stem cells from nonhuman primate templates.
A team of scientists has developed a novel method to detect the culprits behind dust allergies, using PNA-encoded protease substrate microarrays. This innovative approach reveals the specific proteins responsible for triggering allergic reactions in humans, providing new insights into the mechanisms underlying dust allergy.
Researchers explored strategies to combat HIV-1 protease resistance, a key factor in treatment failure. The study identified novel approaches to inhibit the enzyme, offering potential solutions to overcome drug resistance and improve treatment outcomes.
Researchers found that Smad3 protein was present in B-cell and non-lymphocyte samples but almost absent in T-cell samples. In mice, deletion of the Smad3 gene impairs TGF-B's ability to stop T-cell proliferation. Further studies are needed to understand the mechanisms behind Smad3's absence in childhood T-cell leukemia.
Researchers at UT Southwestern Medical Center discovered a protein called NHE1 that regulates cell acidity by directly detecting volume changes. This control is crucial for cell growth and proliferation. The study found specific differences in how NHE1 responds to changes in cell volume compared to another similar transporter, NHE3.
Researchers at SLU have identified the first gene regulating programmed cell death in plant embryos, revealing a previously unknown mechanism. This discovery has significant implications for plant breeding and forestry, as it may help increase production and bolster resistance in plants.
Researchers identified more than 500 proteins contained in the midbody structure necessary for normal cell division. Inactivating these proteins led to cytokinesis defects, causing abnormal cell division, which can lead to diseases such as cancer, birth defects, and neurological disorders.
The joint program aims to expand technical capabilities in systems biology by combining ISB's instrumentation expertise with PNNL's computational powers. Current collaborations include protein structure prediction and whole proteome analysis, with potential applications in disease diagnosis and prevention.
The Oregon Stem Cell Center aims to develop therapies using adult stem cells for human diseases through a rapid approach from basic research to animal trials and human studies. The center's focus will be on the liver and pancreas, building on OHSU's existing expertise in cell therapy.
Dr. Paul Sharpe has received the 2004 Craniofacial Biology Award for his pioneering work in vertebrate body patterning and the molecular basis of tooth development. His contributions to the field have been widely accepted by the scientific community, recognizing his significant impact on craniofacial biology.
Dr. Gibson received the IADR Research in Oral Biology Distinguished Scientist Award for her groundbreaking research. She is recognized as one of the top researchers in the field, with a long history of publishing prestigious papers and serving on numerous review bodies.
The new cell lines, derived from private funds by Harvard University researchers, offer a robust and easy-to-handle alternative to existing human embryonic stem cells. The availability of these cell lines is expected to quicken the pace of discovery in stem cell biology, particularly in research related to type 1 diabetes.
Virginia Tech biologist Virginia Tyson earns top scientist award for his work in computational cell biology and mathematical models of molecular mechanisms controlling cellular growth and division. His research aims to understand and treat medical problems caused by molecular dys-regulation, such as cancer and nerve-cell regeneration.
The new center will integrate basic molecular and cellular research with advanced imaging technologies and computational science to understand complex biological systems. This collaboration aims to develop computer models of entire cells, revolutionizing drug development and reducing costs.
Researchers have discovered that protein cdk6 inhibits breast cancer cell growth, suggesting a promising avenue for diagnosis and treatment. Cdk6 levels were found to be significantly lower in breast cancer cells compared to normal cells, with increased expression of cdk6 linked to suppressed cell growth.
A biochemical chain of events governs cell size in multiple diseases. Researchers discovered that AMPK regulates TSC2 activity, which limits mTOR activity, thereby controlling cell growth. This chain of events may be targeted by the drug Rapamycin to treat genetic syndromes.
Researchers at the University of Texas M.D. Anderson Cancer Center have discovered that ARF is a crucial regulator of both cell growth and division, two critical processes in cancer development. By inhibiting B23, another protein involved in cellular growth, ARF can control the cell cycle and prevent uncontrolled cell proliferation.
Researchers at UCSB have identified a cell survival gene, ICD-1, that prevents normal cells from committing suicide. The discovery may lead to new treatments for degenerative diseases such as ALS, stroke, heart disease, autoimmune disorders, and cancer.
Scientists have identified a signal that triggers half of the stem cells in the developing brain to commit suicide at a certain point in development. This finding may one day help victims of devastating brain diseases such as Alzheimer's, Parkinson's, and stroke by understanding cell death and potential recovery mechanisms.
Researchers at UGA have identified a lipid-protein duo causing massive stem cell death during brain development, but also hinting at potential recovery mechanisms for devastating diseases like Alzheimer's and Parkinson's. The study reveals that this 'deadly couple' leads to the survival of cells destined to form neurons.
Anthony Hyman, group leader at Max Planck Institute of Molecular Cell Biology and Genetics, wins prestigious EMBO Gold Medal. His research focuses on microtubules' role in cell division, shedding light on their dynamics and functions.
Researchers at Max Planck Institute for Cell Biology and Genetics in Dresden and EMBL in Heidelberg have counted the number of proteins that help an egg cell divide. They found that there are more motors pulling on one side, which can pull the centrosome off-center, leading to proper development of the embryo.
Researchers have counted the number of proteins that help an egg cell divide, revealing a crucial difference in motor density between the two poles. This discovery has dramatic consequences for embryonic development and understanding cellular forces.
Researchers have successfully created an artificial egg using somatic cells, a breakthrough that could lead to new treatments for infertility. The study involved transferring the nucleus of a somatic cell into an immature oocyte and then inducing chromosome segregation to produce a haploid egg.
The June issue of Plant Physiology features UCR's Center for Plant Cell Biology, which addresses fundamental questions in plant biology through interdisciplinary approaches. The center's work has significant implications for understanding plant cell function and responses to environmental changes.
The UC Riverside Department of Biology has received a $953,000 GAANN grant to support K-12 outreach efforts. The grant will enable approximately 30 graduate students to participate in research and teaching opportunities while focusing on their Ph.D. degrees.
The E2F3 protein plays a crucial role in controlling cell division. A study found that its absence can lead to increased genetic instability and centrosome proliferation, which may contribute to cancer development. The researchers discovered that cells without E2F3 were more likely to develop into tumors, especially when combined with ...
Scientists at the University of Pittsburgh Medical Center found that chromosomal problems exist within each individual cell, leading to developmental abnormalities. The study suggests that current techniques used for reproductive cloning do not work in nonhuman primates.
Researchers have discovered a new tool that shows how dividing cells complete the final stage of cell division with precision. Blebbistatin inhibits a type of myosin necessary for cytokinesis, revealing its essential role in human biology and cell division.
U of MN researchers identified proteins FRGY2a and FRGY2b that disassemble nucleoli without other protein help. This discovery may lead to understanding normal cell development and human diseases.
Researchers at UIC provided the first images of HIV in living cells, revealing how the virus enlists host assistance to wreak havoc on the body's defenses. The visualization, which took four years to develop, shows HIV particles hitching a ride aboard dynein, a molecular motor, and crossing the microtubular highway to reach the nucleus.